Shares of Castlight Health (NYSE:CSLT) have been assigned a consensus recommendation of “Hold” from the eight analysts that are currently covering the firm, Marketbeat.com reports. One analyst has rated the stock with a sell recommendation, three have given a hold recommendation and four have assigned a buy recommendation to the company. The average twelve-month target price among analysts that have issued a report on the stock in the last year is $5.63.
A number of research firms recently weighed in on CSLT. Chardan Capital reiterated a “buy” rating and issued a $5.75 price objective (down from $6.30) on shares of Castlight Health in a research note on Thursday, February 22nd. Zacks Investment Research upgraded shares of Castlight Health from a “hold” rating to a “buy” rating and set a $3.75 price objective for the company in a research note on Wednesday, January 31st. Cantor Fitzgerald reiterated a “buy” rating and issued a $5.00 price objective on shares of Castlight Health in a research note on Thursday, May 10th. Finally, ValuEngine upgraded shares of Castlight Health from a “sell” rating to a “hold” rating in a research note on Wednesday, May 2nd.
In other Castlight Health news, CEO John C. Doyle sold 21,160 shares of the firm’s stock in a transaction on Thursday, May 17th. The shares were sold at an average price of $3.79, for a total value of $80,196.40. Following the completion of the transaction, the chief executive officer now directly owns 165,672 shares of the company’s stock, valued at approximately $627,896.88. The sale was disclosed in a legal filing with the SEC, which can be accessed through the SEC website. Also, CFO Mangini Siobhan Nolan sold 14,430 shares of the firm’s stock in a transaction on Thursday, May 17th. The shares were sold at an average price of $3.80, for a total transaction of $54,834.00. Following the completion of the transaction, the chief financial officer now directly owns 121,413 shares of the company’s stock, valued at $461,369.40. The disclosure for this sale can be found here. Insiders sold a total of 36,140 shares of company stock valued at $137,120 over the last quarter. 22.58% of the stock is owned by company insiders.
Shares of CSLT stock opened at $3.75 on Thursday. The company has a quick ratio of 2.00, a current ratio of 2.00 and a debt-to-equity ratio of 0.02. Castlight Health has a 12-month low of $3.15 and a 12-month high of $4.75. The company has a market cap of $523.84 million, a PE ratio of -14.42 and a beta of 1.38.
Castlight Health Company Profile
Castlight Health, Inc provides a software-as-a-service platform used for health benefits navigation for employees in the United States. Its platform matches employees to the resources their employers make available to them; managing a condition; and assists them to manage their benefits. The company also offers communication and testing, implementation, and user customer support services.
Receive News & Ratings for Castlight Health Daily - Enter your email address below to receive a concise daily summary of the latest news and analysts' ratings for Castlight Health and related companies with MarketBeat.com's FREE daily email newsletter.